First patient enrolled in a clinical trial to evaluate Brain+' next generation cognitive training ...

Brain+ starts clinical trial of BrainBlossom, its next-gen cognitive training tech for Mild Cognitive Impairment (MCI), in collaboration with Aalborg University Hospital. The trial aims to test the feasibility and impact of BrainBlossom as a home-delivered treatment for MCI, with results expected in early 2025. Success could lead to a larger trial for regulatory data and a partnership for commercialization.